<- Go Home

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.

Market Cap

$41.2B

Volume

4.6M

Cash and Equivalents

$3.7B

EBITDA

$2.1B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$4.8B

Profit Margin

76.60%

52 Week High

$96.12

52 Week Low

$58.93

Dividend

N/A

Price / Book Value

4.32

Price / Earnings

26.94

Price / Tangible Book Value

5.90

Enterprise Value

$37.5B

Enterprise Value / EBITDA

18.01

Operating Income

$1.9B

Return on Equity

19.14%

Return on Assets

10.65

Cash and Short Term Investments

$4.4B

Debt

$706.7M

Equity

$9.6B

Revenue

$6.3B

Unlevered FCF

$1.8B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches